|

Influence of Sodium Intake in spondyLoarthriTes

RECRUITINGN/ASponsored by Centre Hospitalier Universitaire de Besancon
Actively Recruiting
PhaseN/A
SponsorCentre Hospitalier Universitaire de Besancon
Started2024-01-30
Est. completion2026-11
Eligibility
Age18 Years – 80 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06259890

Summary

The aim of the SALT study is to analyze the relationship between dietary sodium intake and disease activity in patients with axial spondyloarthritis (radiographic or non-radiographic) or psoriatic arthritis.

Eligibility

Age: 18 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* patients with axial spondyloarthritis (radiographic or non-radiographic) or psoriatic arthritis
* women who have been menopausal for at least 24 months, surgically sterilized, or, for women of childbearing potentiale, use an effective method of contraception (oral contraceptives, contraceptive injections, intrauterine devices, double-barrier method, contraceptive patches)

Exclusion Criteria:

* patient treated by cyclosporine, diuretics, angiotensin-converting enzyme inhibitors or angiotensin II receptor antagonists.
* current treatment with an anti-IL-17A agent (secukinumab or ixekizumab or bimekizumab or brodalumab) or with an anti-IL23 agent (ustekinumab, guselkumab, risankizumab or tildrakizumab) or previous treatment less than 6 months old.
* patients on systemic corticosteroids with corticosteroid therapy \> 10 mg prednisone equivalent
* pregnant woman

Conditions3

ArthritisArthritis, PsoriaticSpondyloarthritis, Axial

Browse More Trials

Arthritis trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.